alendronate has been researched along with tetracycline in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Bauss, F; Bosies, E; Fleisch, H; Janner, M; Mühlbauer, RC; Schenk, R; Strein, K | 1 |
| Bikle, DD; Currier, PA; Doty, SB; Halloran, BP; Morey-Holton, ER; Tanner, SJ | 1 |
| Antic, VN; Fleisch, H; Mühlbauer, RC | 1 |
| Alferiev, IS; Breuer, E; Cohen, H; Eidelman, N; Golomb, G; Hägele, G; Ornoy, A; Patlas, N; Solomon, V | 1 |
| Di Fiore, PM; Dixit, SN; Koerber, A; Lingen, MW; Sommercorn, LM; Veis, A | 1 |
| Bahar, H; Binderman, I; Herman, A; Yaffe, A | 1 |
| McKiernan, FE; Visekruna, M; Wilson, D | 1 |
| Brunette, DM; Burt, HM; Chakraborti, M; Jackson, JK; Plackett, D | 1 |
| Panarelli, NC | 1 |
2 review(s) available for alendronate and tetracycline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-induced injury in the gastrointestinal tract.
Topics: Alendronate; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Bone Density Conservation Agents; Cation Exchange Resins; Colchicine; Ferrous Compounds; Gastrointestinal Diseases; Gastrointestinal Tract; Gout Suppressants; Humans; Imidazoles; Immunosuppressive Agents; Mycophenolic Acid; Paclitaxel; Polystyrenes; Tetracycline; Tetrazoles | 2014 |
12 other study(ies) available for alendronate and tetracycline
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
BM 21.0955, a potent new bisphosphonate to inhibit bone resorption.
Topics: Alendronate; Animals; Benzoates; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Etidronic Acid; Ibandronic Acid; Injections, Intravenous; Osteoclasts; Pamidronate; Rats; Retinoids; Risedronic Acid; Spectrophotometry, Atomic; Tetracycline; Thyroxine | 1991 |
Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilage.
Topics: Alendronate; Analysis of Variance; Animals; Body Weight; Bone Development; Bone Resorption; Calcification, Physiologic; Calcium; Cartilage; Diphosphonates; Isotope Labeling; Male; Microvilli; Osteoclasts; Proline; Rats; Rats, Sprague-Dawley; Tetracycline; Tibia; Weight-Bearing | 1994 |
Effect of bisphosphonates on the increase in bone resorption induced by a low calcium diet.
Topics: Alendronate; Animals; Bone Resorption; Calcium; Calcium, Dietary; Clodronic Acid; Diphosphonates; Disease Models, Animal; Homeostasis; Ibandronic Acid; Male; Rats; Rats, Wistar; Tetracycline | 1996 |
Bisphosphonates and tetracycline: experimental models for their evaluation in calcium-related disorders.
Topics: Alendronate; Animals; Anti-Inflammatory Agents; Betaine; Bone and Bones; Bone Resorption; Calcinosis; Chelating Agents; Diphosphonates; Edetic Acid; Hindlimb; Hydroxyapatites; Male; Pamidronate; Protein Synthesis Inhibitors; Rats; Structure-Activity Relationship; Tetracycline | 1998 |
Effect of alendronate on immature human dental root explants.
Topics: Alendronate; Bicuspid; Coloring Agents; Culture Media; Culture Techniques; Decalcification Technique; Dentin; Dentinogenesis; Fluorescent Dyes; Humans; Microscopy, Fluorescence; Molar; Statistics as Topic; Tetracycline; Time Factors; Tooth Root; Triazines | 2000 |
Combined local application of tetracycline and bisphosphonate reduces alveolar bone resorption in rats.
Topics: Administration, Topical; Alendronate; Alveolar Bone Loss; Alveolar Process; Animals; Anti-Bacterial Agents; Bone Resorption; Doxycycline; Drug Carriers; Drug Combinations; Drug Synergism; Gelatin Sponge, Absorbable; Male; Mandible; Microradiography; Rats; Rats, Wistar; Surgical Flaps; Tetracycline | 2003 |
Severely suppressed bone turnover and atypical skeletal fragility.
Topics: Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Female; Femoral Fractures; Humans; Middle Aged; Tetracycline | 2008 |
Drug intercalation in layered double hydroxide clay: application in the development of a nanocomposite film for guided tissue regeneration.
Topics: Alendronate; Alkaline Phosphatase; Aluminum Silicates; Animals; Biocompatible Materials; Cell Survival; Cells, Cultured; Clay; Drug Carriers; Drug Combinations; Guided Tissue Regeneration; Hydroxides; Lactic Acid; Nanocomposites; Osteoblasts; Osteogenesis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Surface Properties; Tetracycline | 2011 |